Journal: International Journal of Molecular Sciences
Article Title: Curcumin-Mediated Apoptotic Cell Death in Papillary Thyroid Cancer and Cancer Stem-Like Cells through Targeting of the JAK/STAT3 Signaling Pathway
doi: 10.3390/ijms21020438
Figure Lengend Snippet: Curcumin potentiated the cisplatin-mediated apoptosis of PTC cells via enhanced oxidative stress. ( A ) NAC pretreatment prevented the curcumin- and cisplatin-mediated apoptosis of PTC cells. BCPAP cells were treated with 0 µM and 20 µM of curcumin and 10 µM cisplatin, 20 µM curcumin plus 10 µM cisplatin, NAC (10 mM) and NAC plus 20 µM curcumin and 10 µM cisplatin for 24 h; cells were subsequently stained with fluorescein-conjugated Annexin-V and propidium iodide (PI) and analyzed by flow cytometry; apoptosis was measured; and the percentage of apoptosis relative to untreated cells was calculated. ( B ) NAC pretreatment prevented curcumin- and cisplatin-induced increased ROS generation in PTC cells. BCPAP cells were treated with 0 µM or 20 µM of curcumin and 10 µM of cisplatin alone and in combination or were treated with NAC (10 mM) and NAC + curcumin and cisplatin for 24 h; cells were fixed and subsequently stained with 2′,7′ –dichlorofluorescin diacetate (DCFDA); and images were taken through confocal microscopy at 60X magnification (scale bar: 25 µm). DCFDA is well known for measuring the various ROS species: once it diffuses inside the cells, it gets deacetylated by cellular esterases, leading to the formation of a non-fluorescent compound. Next, cellular ROS oxidized DCFDA into a highly fluorescent compound known as dichlorofluorescein (DCF), which can be detected by fluorescence spectroscopy. ( C ) NAC pretreatment attenuated curcumin- and cisplatin-induced damage in PTC cells. We observed increased nuclear condensation, distorted membrane integrity, moderate chromatin condensation, and nuclear fragmentation in the cells challenged with both cisplatin and curcumin, while the control and NAC-treated cells depicted diffuse nuclear staining with intact membrane integrity. BCPAP cells were treated with 0 µM or 20 µM of curcumin and 10 µM of cisplatin alone and in combination or NAC (10 mM) and NAC + curcumin and cisplatin for 24 h, and cells were fixed and subsequently stained with 4′,6-diamidino-2-phenylindole (DAPI). Images were taken through an EVOS FLc Cell Imaging System from Invitrogen (Thermo Fisher Scientific) at 40× magnification (scale bar: 100 µm). ( D ) NAC prevented curcumin- and cisplatin-induced modulation in the expression of antiapoptotic and proapoptotic proteins in PTC cells. BCPAP cells were pretreated with NAC (10 mM), followed by a combination treatment of 20 µM curcumin and 10 µM cisplatin, and after cell lysis, equal amounts of proteins were separated by SDS-PAGE, transferred to a PVDF membrane, and immunoblotted with antibodies of Bcl2, Bcl-xL, Bax, and Hsp60. ( E ) NAC prevented curcumin- and cisplatin-induced activation of caspase-mediated apoptosis in PTC cells. BCPAP cells were pretreated with NAC (10 mM), followed by a combination treatment of 20 µM curcumin and 10 µM cisplatin, and after cell lysis, equal amounts of proteins were separated by SDS-PAGE, transferred to a PVDF membrane, and immunoblotted with antibodies of caspase-9, cleaved caspase-8, cleaved caspase-3, PARP, and Hsp60. CUR: curcumin; CIS: cisplatin.
Article Snippet: The human papillary thyroid carcinoma cell (PTC) cancer cell lines, BCPAP and TPC-I, were obtained from DSMZ (Braunschh, Germany) and EMD Millipore, MA, USA, respectively, and were cultured using RPMI 1640 medium supplemented with 10% ( v / v ) fetal bovine serum (FBS), 100 U/mL penicillin, and 100 U/mL streptomycin at 37 °C in a humidified atmosphere containing 5% CO2.
Techniques: Staining, Flow Cytometry, Confocal Microscopy, Fluorescence, Spectroscopy, Membrane, Control, Imaging, Expressing, Lysis, SDS Page, Activation Assay